Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Post by PutinKhuylo1on Aug 03, 2017 1:46pm
498 Views
Post# 26543932

My Take

My TakeI was a stockholder much longer than a SH poster. I traded SBM in the beginning (note: NOT flipped), then began accumulating when it dropped precipitously to below a nickel. I've participated in 4 private placements and exercised options. I have not sold a single share since. The transition came as a result of getting to understand the science behind the company. Through the years I've spoken to most of the major players in the company, i.e. Howard Verrico and Neil Belenke, met some of them in person, and even lunched with Attila Hajdu in Philly at a BIO-conference. Quite frankly, I liked all of them. Because of the financial aspects of my connection with SBM, the most exposure has been to Chris Hopton, the CFO, who I believe is as honest as the day is long. Perhaps these relationships are the reason I get upset when I hear mindless buffoons recklessly throwing around unsubstantiated accusations and innuendo. There are real, competent people here who have invested plenty and continue to push this company forward. The mere reality that we're still around as a penny stock on the Venture and in transformational negotiations of any kind (yes, I believe) is a testament to that dedication. Nothing is handed to you on a silver platter. Nothing. Remember also, it takes a few weeks to grow a pumpkin, but decades to cultivate a mighty oak. Hang in there! 
Bullboard Posts